BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©Author(s) (or their employer(s)) 2026.
World J Gastrointest Surg. Feb 27, 2026; 18(2): 113530
Published online Feb 27, 2026. doi: 10.4240/wjgs.v18.i2.113530
Table 5 Key immune indicators for survival prognosis using multivariate Cox regression analysis
VariableOS
DFS
P value
HR (95%CI)
HR (95%CI)
CD8+ IM density > 220/mm20.52 (0.33-0.82)0.61 (0.40-0.93)0.004
CD8+/FoxP3+ ratio > 2.50.69 (0.45-1.06)0.47 (0.29-0.76)0.09
PD-L1+ tumor cells > 10%2.15 (1.32-3.51)1.84 (1.20-2.82)0.001
CD68+CD163+ M2 TC > 85/mm21.43 (0.92-2.22)1.72 (1.10-2.70)0.112


Write to the Help Desk